Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Sarcoma
>>
CD Protein Inhibitors
1
2
»
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
11
22
33
44
55
66
77
88
99
110
sunitinib
/ Generic mfg.
Keytruda
(pembrolizumab) / Merck (MSD)
Opdivo
(nivolumab) / BMS
Tecentriq
(atezolizumab) / Roche
AiRuiKa
(camrelizumab) / HLB Bio Group
Imfinzi
(durvalumab) / AstraZeneca
Ibrance
(palbociclib) / Pfizer
Bavencio
(avelumab) / EMD Serono
Proleukin
(aldesleukin) / Merck (MSD), Novartis, Iovance Biotherap
Tevimbra
(tislelizumab-jsgr) / BeiGene
Kisqali
(ribociclib) / Novartis
Tyvyt
(sintilimab) / Eli Lilly
Jemperli
(dostarlimab-gxly) / GSK
Loqtorzi
(toripalimab-tpzi) / Shanghai Junshi Biosci, Coherus Biosci
Verzenio
(abemaciclib) / Eli Lilly
Libtayo
(cemiplimab-rwlc) / Regeneron
Kaitanni
(cadonilimab) / Akesobio
Enweida
(envafolimab) / 3DMed, Tracon Pharma, Ascletis
Zynyz
(retifanlimab-dlwr) / Incyte
bintrafusp alfa
(M7824) / EMD Serono
spartalizumab
(PDR001) / Novartis
AiRuiKang
(dalpiciclib) / Jiangsu Hengrui Pharma
Anniko
(penpulimab) / Akesobio, Sino Biopharm
Rituxan
(rituximab) / Roche
balstilimab
(AGEN2034) / Agenus
socazolimab
(STI-A1014) / Sorrento
Cosela
(trilaciclib) / G1 Therap
Yutuo
(zimberelimab) / Arcus Biosci, Gilead
alvocidib
(DSP-2033) / Sumitomo Pharma
bempegaldesleukin
(NKTR-214) / Nektar Therap, BMS, Ono Pharma
Omblastys
(131I-omburtamab) / Y-mAbs Therap
Promacta
(eltrombopag) / Novartis
SCRI-CARB7H3(s)x19
/ Seattle Children's Hospital
T3011
/ ImmVira Pharma
benmelstobart
(APL-502) / Apollomics
ezabenlimab
(BI 754091) / Boehringer Ingelheim
izuralimab
(XmAb23104) / Xencor
pepinemab
(VX15) / Vaccinex
sasanlimab
(PF-06801591) / Pfizer
Aibining
(geptanolimab) / Apollomics
Arenegyr
(NGR-hTNF) / AGC Biologics
Blincyto
(blinatumomab) / Astellas, Amgen
CDX-1140
/ Celldex
Campath
(alemtuzumab) / Sanofi
EGFR bi-armed autologous activated T cells
/ Barbara Ann Karmanos Cancer Institute
GI-101
/ GI Innovation
LAE005
/ Laekna Therap
MK-4830
/ Merck (MSD)
Mylotarg
(gemtuzumab ozogamicin) / UCB, PDL, Pfizer
NY-ESO-1 TCR-T cell therapy
/ Gilead
1
2
»